BioTechnique
Private Company
Funding information not available
Overview
BioTechnique is a US-based private CRDMO providing specialized sterile injectable manufacturing, particularly for cytotoxic and high-potency therapeutics. Founded in 2008 and headquartered in York, Pennsylvania, the company offers end-to-end services including formulation development, fill-finish, lyophilization, regulatory support, and project management. Its business model is service-based, generating revenue by partnering with pharmaceutical and biotech companies to bring their injectable drug products to market.
Technology Platform
Integrated aseptic fill-finish and lyophilization platform for sterile injectables, supported by ACE, a proprietary cloud-based Quality Management System (QMS) for real-time compliance and operational visibility.
Opportunities
Risk Factors
Competitive Landscape
BioTechnique competes in the sterile injectable CDMO space against large global players (e.g., Lonza, Catalent, Baxter) and smaller niche specialists. Its differentiation lies in a focused expertise on cytotoxic/high-potency compounds, an in-house integrated service model, and a US-based location, appealing to clients seeking specialized, responsive partners.